Abstract:DNA damage can lead to mutations that can alter the function of oncogenes or tumor suppressor genes, thus promoting the development of cancer. p53 plays a multifaceted and complex role in the DNA damage response and cancer progression and is known as the 'guardian of the gene'. When DNA damage occurs, p53 is activated through a series of post-translational modifications, which stabilize the protein and enhance its function as a transcription factor. It regulates processes including cell cycle checkpoints, DNA repair and apoptosis, thereby preventing the spread of damaged DNA and maintaining genome integrity. On the one hand, p53 can initiate cell cycle arrest and induce cells to enter the G1/S and G2/M checkpoints, preventing cells with damaged DNA from continuing to proliferate and gaining time for DNA repair. At the same time, p53 can promote the activation of DNA repair pathways, including base excision repair, nucleotide excision repair and other repair pathways, to ensure the integrity of genetic material. If the damage is too severe to repair, p53 will trigger the apoptosis process to eliminate potential cancer risks in time. p53 also plays a pivotal role in cancer progression. Mutations in the p53 gene are frequently found in many cancers, and the mutated p53 not only loses its normal tumor suppressor function but may even acquire pro-cancer activity. Therefore, we also discuss therapeutic strategies targeting the p53 pathway, such as the use of small-molecule drugs to restore the function of wild-type p53, the inhibition of negative regulatory factors and synthetic lethality approaches for p53-deficient tumors. This review therefore highlights the important role of p53 in maintaining genomic stability and its potential in therapeutic strategies for cancer.

THE ADVANCE OF STUDY ON P53 TUMOR SUPPRESSOR GENE

[Advances on Mutant P53 Research].

Functional Diversity of P53 in Human and Wild Animals

Resuscitating the Guardian: Current Progress in P53-Based Anti-Tumor Therapy

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Mutant p53 in Cancer Progression and Targeted Therapies

Progress and Prospects: Roles of P53 in Tumor Development

Advancements in p53-Based Anti-Tumor Gene Therapy Research

Mutant P53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Gain-of-function mutant p53 in cancer progression and therapy

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53

Small Molecule Agents Targeting the P53-Mdm2 Pathway for Cancer Therapy

The Development of P53-Targeted Therapies for Human Cancers

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

p53 signaling in cancer progression and therapy

Genetic Mechanisms of Tumor Suppression by the Human p53 Gene

Mutant p53 in cancer therapy-the barrier or the path.

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant